In vivo modeling of diffuse large B cell lymphoma (DLBCL) with the myeloid differentiation primary response gene 88 (MYD88) L265P mutation

被引：1
|
作者：
Ngo, Vu N. [1 ]
机构：
[1] Beckman Res Inst City Hope, Gehr Family Ctr Leukemia Res, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
SOMATIC MUTATION; EXPRESSION; GENOME;
D O I：
10.21037/tcr.2016.10.38
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S852 / S854
页数：3
相关论文
共 50 条
  • [21] MYD88 L265P Mutation Is a Possible Unfavorable Prognostic Factor in Patients with Diffuse B-Cell Lymphoma
    Sidorova, Anna A.
    Zvonkov, Eugene E.
    Sudarikov, Andrey B.
    Severina, Nataliya A.
    Kovrigina, Alla M.
    Troitskaya, Vera V.
    Savchenko, Valeri G.
    BLOOD, 2015, 126 (23)
  • [22] Response to Ibrutinib of a Refractory IgA Lymphoplasmacytic Lymphoma Carrying the MYD88 L265P Gene Mutation
    Quaglia, Francesca Maria
    Rigolin, Gian Matteo
    Saccenti, Elena
    Negrini, Massimo
    Volta, Eleonora
    Dabusti, Melissa
    Ciccone, Maria
    Urso, Antonio
    Laudisi, Michele
    Cuneo, Antonio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11
  • [23] Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation
    Castillo, Jorge J.
    Ghobrial, Irene M.
    Treon, Steven P.
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2699 - 2701
  • [24] MYD88 L265P mutation in intraocular lymphoma: A potential diagnostic marker
    Narasimhan, Sandhya
    Joshi, Mayur
    Parameswaran, Sowmya
    Rishi, Pukhraj
    Khetan, Vikas
    Ganesan, Suganeswari
    Biswas, Jyotirmay
    Sundaram, Natarajan
    Sreenivasan, Janani
    Verma, Sonali
    Krishnamurthy, Vanitha
    Subramanian, Krishnakumar
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (10) : 2160 - 2165
  • [25] Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma
    Taniguchi, Kohei
    Takata, Katsuyoshi
    Chuang, Shih-Sung
    Miyata-Takata, Tomoko
    Sato, Yasuharu
    Satou, Akira
    Hashimoto, Yuko
    Tamura, Maiko
    Nagakita, Keina
    Ohnishi, Nobuhiko
    Noujima-Harada, Mai
    Tabata, Tetsuya
    Kikuti, Yara Yukie
    Maeda, Yoshinobu
    Nakamura, Naoya
    Tanimoto, Mitsune
    Yoshino, Tadashi
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (03) : 324 - 334
  • [26] DOES THE MUTATION IN THE MYD88 L265P GENE IN DIFFUSE LARGE B-CELL LYMPHOMAS HAVE INDEPENDENT DIAGNOSTIC SIGNIFICANCE?
    Kovrigina, A. M.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2024, 69 (04):
  • [27] MYD88 L265P Mutation in Waldenstrom's Macroglogulinemia
    Poulain, Stephanie
    Roumier, Christophe
    Decambron, Audrey
    Renneville, Aline
    Herbaux, Charles
    Bertrand, Elisabeth
    Tricot, Sabine
    Daudignon, Agnes
    Galiegue-Zouitina, Sylvie
    Theisen, Olivier
    Grardel, Nathalie
    Soenen, Valerie
    Nibourel, Olivier
    Roche-Lestienne, Catherine
    Quesnel, Bruno
    Duthilleul, Patrick
    Preudhomme, Claude
    Leleu, Xavier
    BLOOD, 2012, 120 (21)
  • [28] MYD88 L265P Somatic Mutation in IgM MGUS
    Landgren, Ola
    Staudt, Louis
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (23): : 2255 - 2256
  • [29] MYD88 (L265P) Mutation Confers Very Poor Response and Outcome after Second-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Salar, Antonio
    Garcia-Pallarols, Francesc
    Fernandez-Rodriguez, Concepcion
    Sanchez-Gonzalez, Blanca
    Carmen Vela, Mari
    Gimeno, Eva
    Pairet, Silvia
    Senin, Alicia
    Camacho, Laura
    Serrano, Sergi
    Besses, Carlos
    Bellosillo, Beatriz
    BLOOD, 2014, 124 (21)
  • [30] Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
    Li, Wei
    Wang, Ruirui
    Wang, Junhao
    Chai, Dafei
    Xie, Xiaohui
    Young, Ken H.
    Cao, Ya
    Li, Yong
    Yu, Xinfang
    BLOOD, 2025, 145 (10) : 1047 - 1060
12345